Great Lakes Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17M | Buy |
788,035
+175,355
| +29% | +$3.78M | 0.14% | 137 |
|
|
2025
Q1 | $10.2M | Buy |
612,680
+72,667
| +13% | +$1.21M | 0.09% | 192 |
|
|
2024
Q4 | $9.91M | Buy |
+540,013
| New | +$9.91M | 0.08% | 203 |
|
|
2021
Q2 | – | Sell |
-482,666
| Closed | -$12.5M | – | 703 |
|
|
2021
Q1 | $12.5M | Buy |
482,666
+32,152
| +7% | +$830K | 0.2% | 157 |
|
|
2020
Q4 | $24.1M | Buy |
+450,514
| New | +$24.1M | 0.44% | 66 |
|
|
2018
Q4 | – | Sell |
-202,452
| Closed | -$4.2M | – | 558 |
|
|
2018
Q3 | $4.2M | Sell |
202,452
-11,521
| -5% | -$239K | 0.09% | 219 |
|
|
2018
Q2 | $3.27M | Buy |
+213,973
| New | +$3.27M | 0.08% | 252 |
|